Get started
Author

Margaretha E.H. Kaijen-Lambers

Observed names: Margaretha E. H. Kaijen-Lambers, Margaretha E. Kaijen-Lambers, Margaretha E.H. Kaijen, Margaretha E.H. Kaijen‐Lambers, Margaretha Kaijen, Margaretha Kaijen-Lambers
OpenAlex ID: A5080628121
Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy
2017 · Floris Dammeijer, Lysanne A. Lievense, et al. · Cancer Immunology Research · 142
PDF
Tumour‐derived exosomes as antigen delivery carriers in dendritic cell‐based immunotherapy for malignant mesothelioma
2013 · Niken M. Mahaweni, Margaretha E.H. Kaijen‐Lambers, et al. · Journal of Extracellular Vesicles · 119
PDF
Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma
2015 · Robin Cornelissen, Joost P. J. J. Hegmans, et al. · American Journal of Respiratory and Critical Care Medicine · 105
PDF
Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human
2017 · Joachim G.J.V. Aerts, Pauline L. de Goeje, et al. · Clinical Cancer Research · 91
Pleural Effusion of Patients with Malignant Mesothelioma Induces Macrophage-Mediated T Cell Suppression
2016 · Lysanne A. Lievense, Robin Cornelissen, et al. · Journal of Thoracic Oncology · 86
PDF
Low-dose cyclophosphamide depletes circulating naïve and activated regulatory T cells in malignant pleural mesothelioma patients synergistically treated with dendritic cell-based immunotherapy
2018 · Lisanne Noordam, Margaretha E.H. Kaijen, et al. · OncoImmunology · 52
PDF
Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non–small Cell Lung Cancer Patients
2019 · Pauline L. de Goeje, Myrthe Poncin, et al. · Clinical Cancer Research · 43
Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response
2021 · Floris Dammeijer, Cornedine J. De Gooijer, et al. · EBioMedicine · 28
PDF
Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOS
2018 · Pauline L. de Goeje, Yarne Klaver, et al. · Frontiers in Immunology · 22
PDF
Precision immunotherapy; dynamics in the cellular profile of pleural effusions in malignant mesothelioma patients
2016 · Lysanne A. Lievense, Koen Bezemer, et al. · Lung Cancer · 20
Stereotactic Ablative Radiotherapy Induces Peripheral T-Cell Activation in Patients with Early-Stage Lung Cancer
2017 · Pauline L. de Goeje, Egbert F. Smit, et al. · American Journal of Respiratory and Critical Care Medicine · 11
OA13.06 Autologous Dendritic Cells Loaded with Allogeneic Tumor Cell Lysate (Pheralys®) in Patients with Mesothelioma: Final Results of a Phase I Study
2017 · Joachim Aerts, Robin Cornelissen, et al. · Journal of Thoracic Oncology · 6
PDF
Abstract CT229: Autologous dendritic cells loaded with allogeneic tumor cell lysate in patients with mesothelioma: A phase I study
2015 · Joachim G. Aerts, Robin Cornelissen, et al. · Cancer Research · 1
Supplementary Data from Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non–small Cell Lung Cancer Patients
2026 · Pauline L. de Goeje, Myrthe Poncin, et al.
Data from Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non–small Cell Lung Cancer Patients
2026 · Pauline L. de Goeje, Myrthe Poncin, et al.
Data from Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy
2023 · Floris Dammeijer, Lysanne A. Lievense, et al.
Supplemental Figure Legends from Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy
2023 · Floris Dammeijer, Lysanne A. Lievense, et al.
Supplementary Figures S1 through S7 from Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy
2023 · Floris Dammeijer, Lysanne A. Lievense, et al.
Data from Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy
2023 · Floris Dammeijer, Lysanne A. Lievense, et al.
Supplementary Table 1 from Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy
2023 · Floris Dammeijer, Lysanne A. Lievense, et al.
PDF
Supplementary Figures S1 through S7 from Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy
2023 · Floris Dammeijer, Lysanne A. Lievense, et al.
PDF
Supplemental Figure Legends from Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy
2023 · Floris Dammeijer, Lysanne A. Lievense, et al.
Supplementary Table 1 from Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy
2023 · Floris Dammeijer, Lysanne A. Lievense, et al.
Supplementary Data from Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human
2023 · Joachim G.J.V. Aerts, Pauline L. de Goeje, et al.
Data from Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human
2023 · Joachim G.J.V. Aerts, Pauline L. de Goeje, et al.
Works count: 27
Citation count: 726
H-index: 11
I10-index: 11
Year
Topic
Type